BioXcel Therapeutics (BTAI) Misses Q2 EPS by 15c
Tweet
Share
E-mailGet Alerts BTAI Hot Sheet
Join SI Premium – FREE
BioXcel Therapeutics (NASDAQ: BTAI) reported Q2 EPS of ($1.35), $0.15 worse than the analyst estimate of ($1.20).
For earnings history and earnings-related data on BioXcel Therapeutics (BTAI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- FactSet Research Systems (FDS) PT Raised to $253 at Jefferies
- General Mills (GIS) PT Lowered to $42 at Freedom Broker
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
